These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19447902)

  • 1. The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy.
    Zhang S; Lei P; Liu X; Li X; Walker K; Kotha L; Rowlands C; Safe S
    Endocr Relat Cancer; 2009 Sep; 16(3):835-44. PubMed ID: 19447902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells.
    Zhang S; Kim K; Jin UH; Pfent C; Cao H; Amendt B; Liu X; Wilson-Robles H; Safe S
    Mol Cancer Ther; 2012 Jan; 11(1):108-18. PubMed ID: 22034498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin's (TCDDs) induction of cytochrome P4501A1 (CYP1A1) by the putative selective aryl hydrocarbon receptor modulator 6-alkyl-1,3,8-trichlorodibenzofuran (6-MCDF) in the mouse hepatoma cell line Hepa-1c1c7.
    Fretland AJ; Safe S; Hankinson O
    Chem Biol Interact; 2004 Nov; 150(2):161-70. PubMed ID: 15535986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the aryl hydrocarbon receptor ligand 6-methyl-1,3,8-trichlorodibenzofuran with estrogen receptor alpha.
    Pearce ST; Liu H; Radhakrishnan I; Abdelrahim M; Safe S; Jordan VC
    Cancer Res; 2004 Apr; 64(8):2889-97. PubMed ID: 15087408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aryl hydrocarbon receptor (AHR)-active pharmaceuticals are selective AHR modulators in MDA-MB-468 and BT474 breast cancer cells.
    Jin UH; Lee SO; Safe S
    J Pharmacol Exp Ther; 2012 Nov; 343(2):333-41. PubMed ID: 22879383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen and aryl hydrocarbon receptor expression and crosstalk in human Ishikawa endometrial cancer cells.
    Wormke M; Castro-Rivera E; Chen I; Safe S
    J Steroid Biochem Mol Biol; 2000 Apr; 72(5):197-207. PubMed ID: 10822009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status.
    Angus WG; Larsen MC; Jefcoate CR
    Carcinogenesis; 1999 Jun; 20(6):947-55. PubMed ID: 10357772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aryl hydrocarbon receptor-mediated inhibition of LNCaP prostate cancer cell growth and hormone-induced transactivation.
    Morrow D; Qin C; Smith R; Safe S
    J Steroid Biochem Mol Biol; 2004 Jan; 88(1):27-36. PubMed ID: 15026081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different response of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-sensitive genes in human breast cancer MCF-7 and MDA-MB 231 cells.
    Döhr O; Vogel C; Abel J
    Arch Biochem Biophys; 1995 Aug; 321(2):405-12. PubMed ID: 7646066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells.
    Spink DC; Spink BC; Cao JQ; DePasquale JA; Pentecost BT; Fasco MJ; Li Y; Sutter TR
    Carcinogenesis; 1998 Feb; 19(2):291-8. PubMed ID: 9498279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible aryl hydrocarbon receptor-independent pathway of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced antiproliferative response in human breast cancer cells.
    Yoshioka H; Hiromori Y; Aoki A; Kimura T; Fujii-Kuriyama Y; Nagase H; Nakanishi T
    Toxicol Lett; 2012 Jun; 211(3):257-65. PubMed ID: 22521833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro inhibition of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced activity by alpha-naphthoflavone and 6-methyl-1,3,8-trichlorodibenzofuran using an aryl hydrocarbon (Ah)-responsive construct.
    Merchant M; Safe S
    Biochem Pharmacol; 1995 Aug; 50(5):663-8. PubMed ID: 7669069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aryl hydrocarbon receptor activation of an antitumor aminoflavone: basis of selective toxicity for MCF-7 breast tumor cells.
    Loaiza-Pérez AI; Kenney S; Boswell J; Hollingshead M; Alley MC; Hose C; Ciolino HP; Yeh GC; Trepel JB; Vistica DT; Sausville EA
    Mol Cancer Ther; 2004 Jun; 3(6):715-25. PubMed ID: 15210858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative antiestrogenic activities of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 6-methyl-1,3,8-trichlorodibenzofuran in the female rat.
    Astroff B; Safe S
    Toxicol Appl Pharmacol; 1988 Sep; 95(3):435-43. PubMed ID: 2847362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action of aryl hydrocarbon receptor antagonists: inhibition of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced CYP1A1 gene expression.
    Merchant M; Morrison V; Santostefano M; Safe S
    Arch Biochem Biophys; 1992 Nov; 298(2):389-94. PubMed ID: 1329656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel compound, NK150460, exhibits selective antitumor activity against breast cancer cell lines through activation of aryl hydrocarbon receptor.
    Fukasawa K; Kagaya S; Maruyama S; Kuroiwa S; Masuda K; Kameyama Y; Satoh Y; Akatsu Y; Tomura A; Nishikawa K; Horie S; Ichikawa Y
    Mol Cancer Ther; 2015 Feb; 14(2):343-54. PubMed ID: 25522763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of inhibition of MDA-MB-468 breast cancer cell growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Wang WL; Porter W; Burghardt R; Safe SH
    Carcinogenesis; 1997 May; 18(5):925-33. PubMed ID: 9163677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action of alpha-naphthoflavone as an Ah receptor antagonist in MCF-7 human breast cancer cells.
    Merchant M; Krishnan V; Safe S
    Toxicol Appl Pharmacol; 1993 Jun; 120(2):179-85. PubMed ID: 8390116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-dependent induction of aryl hydrocarbon hydroxylase in human breast cancer cell lines and characterization of the Ah receptor.
    Harris M; Piskorska-Pliszczynska J; Zacharewski T; Romkes M; Safe S
    Cancer Res; 1989 Aug; 49(16):4531-5. PubMed ID: 2545344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated induction of aryl hydrocarbon hydroxylase by 6-methyl-1,3,8-trichlorodibenzofuran: mechanistic studies.
    Harris M; Zacharewski T; Astroff B; Safe S
    Mol Pharmacol; 1989 May; 35(5):729-35. PubMed ID: 2542761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.